Evidence map›Paper›PMID 32041293›Full record

ReviewAntioxidants (Basel, Switzerland)2020

Redox Signaling and Advanced Glycation Endproducts (AGEs) in Diet-Related Diseases.

Vanesa Cepas, Massimo Collino, Juan C Mayo, Rosa M Sainz

Open access · goldAbstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed, 1 pooled it
13.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 1 synthesis or guideline pooled it, 190 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Observational
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Current pharmaceutical biotechnology · 2026
    Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Vanesa CepasDepartamento de Morfologia y Biologia Celular, Redox Biology Group. Universidad de Oviedo, 33403 Oviedo, Spain.
Massimo CollinoDipartimento di Scienza e Tecnologia del Farmaco. Università degli Studi di Torino, 10125 Torino, Italy.ORCID 0000-0001-8782-3496
Juan C MayoDepartamento de Morfologia y Biologia Celular, Redox Biology Group. Universidad de Oviedo, 33403 Oviedo, Spain.
Rosa M SainzDepartamento de Morfologia y Biologia Celular, Redox Biology Group. Universidad de Oviedo, 33403 Oviedo, Spain.
Universidad de Oviedo · ESUniversity of Turin · IT

Funding

Joint Programming Initiative A healthy diet for a healthy life 25/1.09.2017Ministerio de Economía, Industria y Competitividad, Gobierno de España MINECO-17-PCIN-2016-164
6 · The paper itself

Abstract

Diets are currently characterized by elevated sugar intake, mainly due to the increased consumption of processed sweetened foods and drinks during the last 40 years. Diet is the main source of advanced glycation endproducts (AGEs). These are toxic compounds formed during the Maillard reaction, which takes place both in vivo, in tissues and fluids under physiological conditions, favored by sugar intake, and ex vivo during food preparation such as baking, cooking, frying or storage. Protein glycation occurs slowly and continuously through life, driving AGE accumulation in tissues during aging. For this reason, AGEs have been proposed as a risk factor in the pathogenesis of diet-related diseases such as diabetes, insulin resistance, cardiovascular diseases, kidney injury, and age-related and neurodegenerative diseases. AGEs are associated with an increase in oxidative stress since they mediate the production of reactive oxygen species (ROS), increasing the intracellular levels of hydrogen peroxide (H

Indexed as

advanced glycation productsantioxidantsdiet-related diseasesRAGE

Identifiers

PMID32041293
PMCPMC7070562
OpenAlexW3004626042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.